The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Altered gene expression of histone deacetylases in mood disorder patients
Abstract
Chromatin remodeling such as changes in histone acetylation has been suggested to play an important role in the pathophysiology and treatment of mood disorders. In the present study, we investigated whether the expression of histone deacetylase (HDAC) genes are altered in mood disorder patients. We used quantitative real-time PCR to measure the mRNA levels of 11 HDACs (HDAC1-11) in peripheral white blood cells of major depressive disorder (MDD) and bipolar disorder (BPD) patients during depressive and remissive episodes and in the first-degree relatives of BPD patients. In addition, we investigated the effect of antidepressants and mood stabilizers on the mRNA levels of HDACs using mice. In MDD, the expression of HDAC2 and -5 mRNA was increased in a depressive state, but not in a remissive state, compared to controls. In BPD, the expression of HDAC4 mRNA was increased only in a depressive state, and the expression of HDAC6 and -8 was decreased in both depressive and remissive states compared to controls, whereas the first-degree relatives did not show any significant alteration in expression levels. Animal study showed that the expression of HDAC2 and -5 or HDAC4, -6 and -8 mRNAs in the mouse leukocytes were not affected by chronic treatment with antidepressants or mood stabilizers. Our data suggest that aberrant transcriptional regulation caused by the altered expression of HDACs is associated with the pathophysiology of mood disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Interestingly, upon remission, the levels normalized to those of healthy controls”
From Epigenetics and depression (2019) · cites this paper as [25]
In the citing paper
“highlighting the potential of HDAC levels to be used as a biomarker for disease monitoring.”
From Epigenetics and depression (2019) · cites this paper as [25]
In the citing paper
“One study found elevated HDAC2 and HDAC5 levels in patients experiencing an acute depressive episode.”
From Epigenetics and depression (2019) · cites this paper as [25]
In the citing paper
“differential brain expression of HDACs was found in the postmortem in MDD.130,159”
From Epigenetic regulation in major depression and other stress-related disorders: molecular mechanisms, clinical relevance and therapeutic potential (2023) · cites this paper as [159]
In the citing paper
“Expression of HDAC2 and HDAC5 was higher during a depressive state, compared with remission, in peripheral white blood cells of patients diagnosed with MDD and bipolar disorder (BPD).159”
From Epigenetic regulation in major depression and other stress-related disorders: molecular mechanisms, clinical relevance and therapeutic potential (2023) · cites this paper as [159]
In the citing paper
“The expression of HDAC6 and HDAC8 was lower regardless of mood states compared with controls in BPD, while the HDAC4 expression was higher only in a depressive state.159”
From Epigenetic regulation in major depression and other stress-related disorders: molecular mechanisms, clinical relevance and therapeutic potential (2023) · cites this paper as [159]
In the citing paper
“Higher levels of HDAC4 and HDAC5 were found in depressed patients.”
From Epigenetic mechanisms of major depression: Targeting neuronal plasticity (2018) · cites this paper as [81]
In the citing paper
“Further, some reports have shown increased HDAC2 expression and reduced GDNF expression in patients with MDD”
From Epigenetic mechanisms of major depression: Targeting neuronal plasticity (2018) · cites this paper as [81]
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,845
Stress and the brain: from adaptation to disease
de Kloet, E. R., Joëls, M., & Holsboer, F. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1683 · Cited by 4,621
Depression: a new animal model sensitive to antidepressant treatments
PORSOLT, R. D., LE PICHON, M., & JALFRE, M. (1977) · Nature · doi:10.1038/266730a0 · Cited by 4,451
Nestler, E. J., Barrot, M., DiLeone, R. J., Eisch, A. J., Gold, S. J., & Monteggia, L. M. (2002) · Neuron · doi:10.1016/s0896-6273(02)00653-0 · Cited by 3,217
Histone acetylation in chromatin structure and transcription
Grunstein, M. (1997) · Nature · doi:10.1038/38664 · Cited by 2,884
The Corticosteroid Receptor Hypothesis of Depression
Holsboer, F. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00159-7 · Cited by 2,181
Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells
Göttlicher, M., Minucci, S., Zhu, P., Krämer, O. H., Schimpf, A., Giavara, S., Sleeman, J. P., Coco, F. L., Nervi, C., Pelicci, P. G., et al. (2001) · The EMBO Journal · doi:10.1093/emboj/20.24.6969 · Cited by 1,930
Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action
Tsankova, N. M., Berton, O., Renthal, W., Kumar, A., Neve, R. L., & Nestler, E. J. (2006) · Nature Neuroscience · doi:10.1038/nn1659 · Cited by 1,780
Phiel, C. J., Zhang, F., Huang, E. Y., Guenther, M. G., Lazar, M. A., & Klein, P. S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101287200 · Cited by 1,758
New approaches to antidepressant drug discovery: beyond monoamines
Berton, O., & Nestler, E. J. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1846 · Cited by 1,589
Assessing antidepressant activity in rodents: recent developments and future needs
Cryan, J. F., Markou, A., & Lucki, I. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(02)02017-5 · Cited by 1,551 · cited 1×
“First, we evaluated the antidepressant effects of clomipramine, paroxetine, lithium and valproate using the forced swim test, which is highly reliable and has a strong predictive validity for antidepressant compounds (Cryan et al., 2002; Dulawa et al., 2004; Porsolt et al., 1977).”
Epigenetic regulation in psychiatric disorders
Tsankova, N., Renthal, W., Kumar, A., & Nestler, E. J. (2007) · Nature reviews. Neuroscience · doi:10.1038/nrn2132 · Cited by 1,400
Carlezon, W. A., Duman, R. S., & Nestler, E. J. (2005) · Trends in Neurosciences · doi:10.1016/j.tins.2005.06.005 · Cited by 1,382
Diagnostic and Statistical Manual of Mental Disorders
Preedy, V., & Watson, R. (2010) · Springer eBooks · doi:10.1007/978-0-387-78665-0_5485 · Cited by 1,146
CBP Histone Acetyltransferase Activity Is a Critical Component of Memory Consolidation
Korzus, E., Rosenfeld, M. G., & Mayford, M. (2004) · Neuron · doi:10.1016/j.neuron.2004.06.002 · Cited by 823
Epigenetic mechanisms in memory formation
Levenson, J. M., & Sweatt, J. D. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1604 · Cited by 767
Chromatin Remodeling Is a Key Mechanism Underlying Cocaine-Induced Plasticity in Striatum
Kumar, A., Choi, K.-H., Renthal, W., Tsankova, N. M., Theobald, D. E. H., Truong, H.-T., Russo, S. J., LaPlant, Q., Sasaki, T. S., Whistler, K. N., et al. (2005) · Neuron · doi:10.1016/j.neuron.2005.09.023 · Cited by 764
Ito, K., Barnes, P. J., & Adcock, I. M. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.18.6891-6903.2000 · Cited by 723
Rhythmic histone acetylation underlies transcription in the mammalian circadian clock
Etchegaray, J.-P., Lee, C., Wade, P. A., & Reppert, S. M. (2003) · Nature · doi:10.1038/nature01314 · Cited by 679
Effects of Chronic Fluoxetine in Animal Models of Anxiety and Depression
Dulawa, S. C., Holick, K. A., Gundersen, B., & Hen, R. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300433 · Cited by 671
The combined dexamethasone/CRH test: A refined laboratory test for psychiatric disorders
Heuser, I., Yassouridis, A., & Holsboer, F. (1994) · Journal of Psychiatric Research · doi:10.1016/0022-3956(94)90017-5 · Cited by 662
Antidepressant-Like Effects of the Histone Deacetylase Inhibitor, Sodium Butyrate, in the Mouse
Schroeder, F. A., Lin, C. L., Crusio, W. E., & Akbarian, S. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.06.036 · Cited by 541
Epigenetic targets of HDAC inhibition in neurodegenerative and psychiatric disorders
Abel, T. G., & Zukin, R. S. (2008) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2007.12.002 · Cited by 504
Guan, Z., Giustetto, M., Lomvardas, S., Kim, J.-H., Miniaci, M. C., Schwartz, J. H., Thanos, D., & Kandel, E. R. (2002) · Cell · doi:10.1016/s0092-8674(02)01074-7 · Cited by 497
Loss-of-Function Mutation in Tryptophan Hydroxylase-2 Identified in Unipolar Major Depression
Zhang, X., Gainetdinov, R. R., Beaulieu, J.-M., Sotnikova, T. D., Burch, L. H., Williams, R. B., Schwartz, D. A., Krishnan, K. R. R., & Caron, M. G. (2005) · Neuron · doi:10.1016/j.neuron.2004.12.014 · Cited by 473
Webster, M. J., Knable, M. B., O'Grady, J., Orthmann, J., & Weickert, C. S. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001139 · Cited by 420
Regulation of Neuronal Traits by a Novel Transcriptional Complex
Ballas, N., Battaglioli, E., Atouf, F., Andrés, M. E., Chenoweth, J. G., Anderson, M. E., Bürger, C., Moniwa, M., Davie, J., Bowers, W. J., et al. (2001) · Neuron · doi:10.1016/s0896-6273(01)00371-3 · Cited by 416
Brain Chromatin Remodeling: A Novel Mechanism of Alcoholism
Pandey, S. C., Ugale, R. R., Zhang, H., Tang, L., & Prakash, A. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.5731-07.2008 · Cited by 385
Holsboer, F., Lauer, C. J., Schreiber, W., & Krieg, J.-C. (2008) · Neuroendocrinology · doi:10.1159/000127023 · Cited by 369
Finding the Intracellular Signaling Pathways Affected by Mood Disorder Treatments
Coyle, J. T., & Duman, R. S. (2003) · Neuron · doi:10.1016/s0896-6273(03)00195-8 · Cited by 360
Heuser, I. J. E., Schweiger, U., Gotthardt, U., Schmider, J., Lammers, C.-H., Dettling, M., Yassouridis, A., & Holsboer, F. (1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.1.93 · Cited by 275
Impaired feedback regulation of XBP1 as a genetic risk factor for bipolar disorder
Kakiuchi, C., Iwamoto, K., Ishiwata, M., Bundo, M., Kasahara, T., Kusumi, I., Tsujita, T., Okazaki, Y., Nanko, S., Kunugi, H., et al. (2003) · Nature Genetics · doi:10.1038/ng1235 · Cited by 272
Histone deacetylase inhibitors: Understanding a new wave of anticancer agents
Villar‐Garea, A., & Esteller, M. (2004) · International Journal of Cancer · doi:10.1002/ijc.20372 · Cited by 247
Chromatin remodeling in neural development and plasticity
Hsieh, J., & Gage, F. H. (2005) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2005.09.002 · Cited by 230
Otto, S. J., McCorkle, S., Hover, J., Conaco, C., Han, J., Impey, S., Yochum, G. S., Dunn, J. J., Goodman, R. H., & Mandel, G. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.0091-07.2007 · Cited by 226
Uchida, S., Nishida, A., Hara, K., Kamemoto, T., Suetsugi, M., Fujimoto, M., Watanuki, T., Wakabayashi, Y., Otsuki, K., McEwen, B. S., et al. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06218.x · Cited by 203
Self-citationIntracellular Trafficking of Histone Deacetylase 4 Regulates Neuronal Cell Death
Bolger, T. A., & Yao, T. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.1826-05.2005 · Cited by 190
Manji, H. K., Bebchuk, J. M., Moore, G. J., Glitz, D. A., Hasanat, K., & Chen, G. (1999) · PubMed · Cited by 170
Cryan, J. F., & Leonard, B. E. (2000) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/(sici)1099-1077(200003)15:2 · Cited by 167
Altered expression of neurotrophic factors in patients with major depression
Otsuki, K., Uchida, S., Watanuki, T., Wakabayashi, Y., Fujimoto, M., Matsubara, T., Funato, H., & Watanabe, Y. (2008) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2008.01.010 · Cited by 163
Self-citationEpigenetic Mechanisms and Gene Networks in the Nervous System
Colvis, C. M., Pollock, J. D., Goodman, R. H., Impey, S., Dunn, J. J., Mandel, G., Champagne, F. A., Mayford, M. R., Korzus, E., Kumar, A., et al. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.4119-05.2005 · Cited by 141
The behavioral actions of lithium in rodent models: Leads to develop novel therapeutics
O’Donnell, K. C., & Gould, T. D. (2007) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2007.04.002 · Cited by 137
Altered expression of neurotrophic factors in patients with major depression
大朏, 孝. (2008) · Medical Entomology and Zoology · Cited by 128
Molecular mechanisms of immunomodulatory activity of glucocorticoids
Riccardi, C., Bruscoli, S., & Migliorati, G. (2002) · Pharmacological Research · doi:10.1006/phrs.2002.0969 · Cited by 108
Altered HDAC5 and CREB mRNA expressions in the peripheral leukocytes of major depression
Iga, J.-I., Ueno, S.-I., Yamauchi, K., Numata, S., Kinouchi, S., Tayoshi-Shibuya, S., Song, H., & Ohmori, T. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2006.12.014 · Cited by 105
Law, J. W. S., Lee, A. Y. W., Sun, M., Nikonenko, A. G., Chung, S. K., Dityatev, A. E., Schachner, M., & Morellini, F. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-32-10419.2003 · Cited by 103
Reduced Glucocorticoid Receptor α Expression in Mood Disorder Patients and First-Degree Relatives
Matsubara, T., Funato, H., Kobayashi, A., Nobumoto, M., & Watanabe, Y. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.09.026 · Cited by 94
Self-citationAlterations in kynurenine precursor and product levels in schizophrenia and bipolar disorder
Miller, C. L., Llenos, I. C., Cwik, M. F., Walkup, J. T., & Weis, S. (2008) · Neurochemistry International · doi:10.1016/j.neuint.2008.01.013 · Cited by 81
Association analysis of FEZ1 variants with schizophrenia in Japanese cohorts
Yamada, K., Nakamura, K., Minabe, Y., Iwayama‐Shigeno, Y., Takao, H., Toyota, T., Hattori, E., Takei, N., Sekine, Y., Suzuki, K., et al. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.08.015 · Cited by 81
Shabbeer, S., Kortenhorst, M. S. Q., Kachhap, S. K., Galloway, N. L., Rodriguez, R., & Carducci, M. A. (2007) · The Prostate · doi:10.1002/pros.20587 · Cited by 80
Clark, J. A., Flick, R. B., Pai, L.-Y., Szalayova, I., Key, S., Conley, R., Deutch, A. Y., Hutson, P. H., & Mezey, É. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4002041 · Cited by 75
Increased Apoptosis in Patients with Major Depression: A Preliminary Study
Eilat, E., Mendlovic, S., Doron, A., Zakuth, V., & Spirer, Z. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.1.533 · Cited by 69
Laifenfeld, D., Karry, R., Klein, E., & Ben‐Shachar, D. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.12.016 · Cited by 57
Signs of apoptosis of immunocompetent cells in patients with depression
Ivanova, S. А., Semke, V. Y. A., Vetlugina, T. P., Rakitina, N. M., Kudyakova, T. A., & Simutkin, G. G. (2007) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-007-0047-y · Cited by 51
Wakabayashi, Y., Uchida, S., Funato, H., Matsubara, T., Watanuki, T., Otsuki, K., Fujimoto, M., Nishida, A., & Watanabe, Y. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.03.005 · Cited by 32
Self-citationChromatin Remodeling: A Novel Mechanism of Psychotropic Drug Action
Newton, S. S., & Duman, R. S. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.027078 · Cited by 29
Gene and Expression Analyses Reveal Enhanced Expression of Pericentrin 2 (PCNT2) in Bipolar Disorder
Anitha, A., Nakamura, K., Yamada, K., Iwayama, Y., Toyota, T., Takei, N., Iwata, Y., Suzuki, K., Sekine, Y., Matsuzaki, H., et al. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.07.010 · Cited by 27
Cited by
Sorted by citations
Pathogenesis of depression: Insights from human and rodent studies
Ménard, C., Hodes, G. E., & Russo, S. J. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2015.05.053 · Cited by 593
Epigenetics of the depressed brain: role of histone acetylation and methylation
Sun, H., Kennedy, P. J., & Nestler, E. J. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2012.73 · Cited by 413
Molecular adaptations of the blood–brain barrier promote stress resilience vs. depression
Dudek, K. A., Dion-Albert, L., Lebel, M., LeClair, K., Labrecque, S., Tuck, E., Ferrer Perez, C., Golden, S. A., Tamminga, C., Turecki, G., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1914655117 · Cited by 361
Epigenetic Mechanisms of Depression and Antidepressant Action
Vialou, V., Feng, J., Robison, A. J., & Nestler, E. J. (2013) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010611-134540 · Cited by 277
Penner-Goeke, S., & Binder, E. B. (2019) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2019.21.4/ebinder · Cited by 254
Metadata
- Authors
- Hobara, T., Uchida, S., Otsuki, K., Matsubara, T., Funato, H., Matsuo, K., Suetsugi, M., & Watanabe, Y.
- Affiliations
- Yamaguchi University (JP)
- Corresponding author
- Watanabe, Yoshifumi
- Venue
- Journal of Psychiatric Research
- Publisher
- Elsevier BV
- Published
- 2010-04
- Volume
- 44
- Issue
- 5
- Pages
- 263-270
- ISSN
- 0022-3956 (ISSN-L)
- OpenAlex
- W2148160168
- Cited by
- 185
- References
- 57
- Citations by year
- 2026: 9 · 2025: 7 · 2024: 9 · 2023: 6 · 2022: 7 · 2021: 17 · 2020: 18 · 2019: 11 · 2018: 10 · 2017: 16 · 2016: 10 · 2015: 15 · 2014: 9 · 2013: 16 · 2012: 9
- FWCI
- 3.35
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Psychiatric Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Ministry of Education, Culture, Sports, Science and Technology
- Ministry of Health, Labour and Welfare
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Keywords
- histone deacetylase, mood disorders, major depressive disorder, bipolar disorder, HDAC2, HDAC5, HDAC4, HDAC6, HDAC8, gene expression, peripheral blood leukocytes, leukocytes, histone acetylation, chromatin remodeling, antidepressants, mood stabilizers, first-degree relatives
- MeSH terms
- Animals, Antidepressive Agents, Clomipramine, Corticotropin-Releasing Hormone, Dexamethasone, Disease Models, Animal, Female, Gene Expression Regulation, Histone Deacetylases, Humans, Hydrocortisone, Male, Mice, Inbred BALB C, Mice, Inbred C57BL, Middle Aged, RNA, Messenger, Swimming, Paroxetine, Mood Disorders, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
